Search Results 1-10 of 17944 for Receptor

  1. Overview - Molecular Pharmacology of G Protein-coupled Receptors Lab - Mayo Clinic Research

    The Mayo Clinic Molecular Pharmacology of G Protein-Coupled Receptors of Laurence J. Miller, M.D., Lab studies GCPR structure, function and regulation.

  2. Angiotensin II receptor blockers - Mayo Clinic

    In addition to treating high blood pressure, angiotensin 2 receptor blockers may prevent, treat or improve symptoms in people who have: Chronic kidney disease.

  3. Steven M. Sine, Ph.D. - Mayo Clinic Faculty Profiles

    D., in his Receptor Biology Laboratory, investigates the function of neurotransmitter receptors — a class of signaling proteins that mediate moment-to-moment ...

  4. MUC1 TCell receptor repertoire - Mayo Clinic

    About this study. Can T cell receptor repertoires serve as a biomarker of T cell response to a MUC1 vaccine? Participating Mayo Clinic locations.

  5. Breast cancer types: What your type means - Mayo Clinic

    Treatment with endocrine therapy blocks the growth of the cancer cells. Hormone receptor (HR) negative. This type of cancer doesn't have hormone receptors, so ...

  6. Contribution of GLP-1 Receptor - Mayo Clinic

    The GLP-1 receptor gene is found on the beta cells of the pancreas. Its role is in the control of blood sugar level by enhancing insulin secretion from the ...

  7. Histamine H2 Antagonist (Oral Route, Injection Route, Intravenous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Histamine H2-receptor antagonists, also known as H2-blockers, are used to treat duodenal ulcers and prevent their return. They are also ...

  8. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

    Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic ...

  9. CAR-T Cell Therapy Program - Department home - Mayo Clinic

    Chimeric antigen receptor (CAR)-T cell therapy, also known as CAR -T cell therapy, was approved by the Food and Drug Administration in October 2017. CAR -T ...

  10. T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds

    “The presence of costimulatory receptors on the cell surface allows the immune system to better recognize and attack cancer cells,” says Dr. Yang. “We also ...